Skip to main content

Closed

TLX: Telix Pharmaceuticals Limited Financial Statements & Revenue | finqOS

Healthcare · Biotechnology

52W Range

45thpctl

Volume

0.50×avg

Market Cap

3.35BUSD

P/E Ratio

-442.7TTM

Div Yield

-ann

Telix Pharmaceuticals Limited

TLXNASDAQ·USD·Closed

Telix Pharmaceuticals Limited

TLXNASDAQ·USD·Closed

$9.89

−1.69%

$9.89

−$0.17 (1.69%)

52W Range

45thpctl

Volume

0.50×avg

Mkt Cap

3.35BUSD

P/E

-442.7TTM

Div Yield

–ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings